2026 · 3rd Quarter (July 1 - Sep 30)
Filed by WESTMORELAND160, LLC.
Open official filingSource-reported fields
Literal source text
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Literal federal measure citations: H.R.9495, H.R.8800, S.4784, H.R. 6500
Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)
Literal federal measure citations: H.R.9495, H.R.8800, S.4784, H.R. 6500
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
